NYSE MKT LLC · IBIO
-2.72% · -$0.0400 · Vol 755.2K
Market closed · last close 4:00 PM ET · price as of 19:56:06 ET
iBio Inc
Biotechnology
$1.43
Veridion Score
BETALOW CONF · 4/6 factorsFri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET · IBIO
MethodologyEarnings absence reason unknown · Sentiment absence reason unknown
IBIO
iBio Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
NEUTRAL
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
51/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is IBIO moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About iBio Inc
PHARMACEUTICAL PREPARATIONSListed since
2008
Employees
20
Country
US
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$1.46
Day high
$1.50
Day low
$1.42
Previous close
$1.47
52W high
$3.07
-53.42% from high
52W low
$0.7871
28% of range
Market cap
$71M
EPS
$-0.7500
Beta
1.30
Shares out
49.7M
Volume
755.2K
0.96× rel vol
Avg volume
788.2K
VWAP
$1.46
Price history computed in-house
1W
-1.38%
1M
0.00%
3M
-21.43%
1Y
+80.78%
YTD
-25.91%
SMA 50 $1.51 · below
SMA 200 $1.84 · below
52W position 28%
IBIO overview
Related filings and maps
Public disclosures
Congress activity in IBIO
No receipt-qualified Congressional disclosure is present for IBIO in the cached public ledger.
Federal contracts
IBIO contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for IBIO in this window.
Lobbying spend
IBIO lobbying filings, year to date.
Registered lobbying filings matched to iBio Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for IBIO in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for IBIO.
Options
Sovereign unlock shows live options positioning for IBIO.